AI Is Eating Regulated Industries — And That's a Signal for Where to Build Next
🎧 Prefer to listen? Your browser does not support the audio element. Three of the most valuable AI researchers in the world just left their $500K-plus jobs to build in an industry where you can’t ship a product without a decade of regulatory approval. That’s not a career mistake — it’s a signal. Miles Wang left OpenAI to launch a drug discovery startup at a $2 billion valuation. Anthropic is developing drugs directly with Claude Science. Google DeepMind spinout Isomorphic Labs raised $2.1 billion. Chai Discovery hit a $3.8 billion valuation. This isn’t a trend — it’s a coordinated migration of AI talent into the most locked-down industries on the planet. And if you’re a solo builder, the implications go way beyond biotech. I covered Wang’s original move when the news broke, but the bigger picture is what matters here. ...